Cold-chain logistics play a pivotal role in pharmaceutical supply, ensuring patient safety and trial continuity. This is especially true in the oncology sector, where most therapies are temperature-sensitive and in high demand, amplifying the need for robust cold-chain infrastructure. Cold-chain logistics refers to the temperature-controlled transport and storage of pharmaceutical products. For biologics, cell and gene therapies and many oncology medications, maintaining a na

The movement of investigational medicinal products (IMPs) and comparators across borders can be a complex undertaking with customs regulations, import/export requirements, and VAT considerations. CSI supports its clients by removing this complexity and ensuring that clinical supplies move efficiently, compliantly and without delay. Global expertise, local execution Our team has extensive experience navigating country-specific regulations, documentation requirements, and impor

CSI’s colleagues in China attended Bio China this week, connecting with innovators across the biotech ecosystem and discussing how we can support efficient clinical development. Next week, the same venue will host CMAC, and our team will be there again. If you're attending, we’d love to meet and explore how CSI can support your clinical supply needs in APAC:  www.csint.com/contact-us

Clinical Services International (CSI)  will be attending  Infarma  in Madrid on the 24th–26th March. Get in touch if you’re attending, this is a great opportunity to meet with CSI’s Project Management team to discuss your clinical trial pipeline and comparator sourcing needs. Set up a meeting with us in Madrid here:  www.csint.com/contact-us

Clinical Services International (CSI)  will be attending CMAC Suzhou from 18–20th March. Our Business Development Managers  Chenguang Li  and Hayley Zhai from CSI’s Shanghai office will be on site and would be delighted to meet during the conference. If you’d like to discuss your Asia-Pacific clinical supply or comparator sourcing enquiries, we’d love to connect and explore how CSI can support your studies across the region. Looking forward to seeing you in Suzhou! Let’s set

Understanding the Impact of Tariffs on Clinical Trials Recent headlines about proposed US tariffs on European countries highlight the volatility of the global trade environment. As reported this week in Fierce Pharma , potential new duties on several European nations raise questions about the future of US–EU trade relations. This uncertainty can significantly impact the pharmaceutical industry. For sponsors running global clinical trials, this kind of uncertainty translates i

Client:  Mid-size biotech conducting multiple clinical trials Challenge: The client required a large quantity of Humira (adalimumab) for several upcoming studies. High costs and limited availability were putting pressure on study budgets and timelines. Solution: CSI leveraged its industry insight and direct relationships with the manufacturer to provide access to a high-quality adalimumab biosimilar. This saved the client a staggering 50% on price . By carefully coordinating

CSI's Managing Director, Vanessa Dekou PhD, MBA, hosted an inspiring talk at Imperial College London 's Entrepreneurship course, sharing the story behind the creation of Clinical Services International. By identifying a clear gap in the clinical supply market, Vanessa built CSI with a vision to deliver smarter, more agile solutions for global clinical trials. The session was highly engaging and extremely well received, sparking curiosity and ambition among the next generation

On the 12th day of Christmas CSI gave to me…   Twelve reasons sponsors trust CSI, all year long! On the 1st day of Christmas CSI gave to me…  Direct Manufacturer Access! Receive faster timelines and documentation thanks to CSI’s direct accounts with global pharma leaders. Reach out to CSI for a sourcing consultation, no matter how big or small your request. On the 2nd day of Christmas CSI gave to me… Unmatched sustainability; with an EcoVadis Platinum rating, putting us in t

As we prepare for Q1 2026, sponsors and CROs face a shifting global landscape for clinical trial comparator sourcing that focuses on sustainability, diversity and fair pricing. With our EcoVadis Platinum certification, women-owned business status and full scientific team in place, CSI is well placed to support our partner’s supply chains. 1. Supply-chain volatility is real Clinical supplies are increasingly challenged by geo-political pressures, export controls, and manufactu

By Clinical Services International As a proud Women-Owned Business , Clinical Services International (CSI)  is committed to transforming the global clinical supply landscape while championing gender equity and social responsibility. Founded on the principles of scientific excellence, ethical sourcing and diversity, CSI  stands at the forefront of pharmaceutical procurement and supply solutions for clinical trials worldwide. Women-owned businesses are vital to the global econo

As part of our ongoing commitment to excellence and continuous improvement, CSI is proud to announce the digitalization of our Quality Management System (QMS) through Simploud , a leading eQMS platform.   This transition marks an important milestone in enhancing both our customer and supplier experience, ensuring greater efficiency, transparency and compliance across our global operations.   Simploud ’s unified platform will streamline key quality processes (including CAPA ma

October is Breast Cancer Awareness Month and  Clinical Services International (CSI)  is wearing pink to show our solidarity with the cause. Pink is the colour of the ribbon that represents breast cancer awareness. Wearing pink on this day is a way to express support for breast cancer survivors, remember those lost to the disease and advocate for the progress in the fight against breast cancer. Reach out to CSI for your Breast Cancer studies, let's beat Breast Cancer together.

At CSI, we’ve built our reputation on being a trusted partner in advancing global health. Among our proudest achievements is our role in...

When it comes to sourcing medicines for Acute Myeloid Leukemia (AML), a supply partner with experience is imperative. At CSI, we’ve built...

At CSI, we understand the urgency and precision required in ophthalmology research. Among the most pressing areas is wet age-related...

Strategy Partnerships for Budget Value As we enter Q4, many clinical operations teams face the familiar challenge of budget utilization....

Rare disease clinical trials present a distinct set of challenges that make sourcing strategies critical to study success. With fewer...

On 17th–18th September, our Director of Project Management, Stephan Muetze , and Project Manager, Aylin Asadian , will be on-site at the...

In the pharmaceutical industry, timelines serve as both operational benchmarks and market signals. When sponsors announce trial starts...